First In-Human Trial
Clinically Validated Research
Successful Perioperative
Treatment
We believe that patients deserve to know that the neuroregenerative therapy they receive is safe, effective, and based on solid evidence from robust clinical trials. Our TPNS system has been clinically tested and designed to help improve nerve regeneration after surgery.
The Therapy
A single 1-hour dose of electrical stimulation accelerates and enhances sensory nerve regeneration after digital nerve repair. The REGAIN Trial will apply this neuroregenerative therapy from PeriPulse™ in the same validated clinical model.
If you want to read more about our therapy, please visit our PeriPulse™ page for more information.
Key Findings From Our Trial
The TPNS System has been proven to be an effective treatment for nerve injury. The study has been validated in 4 different nerve injury sites with a total of 110 patients using the Grass SD9 system.*
50% Increase in Motor
Outcomes
Patients who have received electrical stimulation have experienced significant improvements in motor function, surpassing our current standard of care.
40% Increase in
Sensory Outcomes
The TPNS System has been proven to be effective in improving sensory acuity, discrimination, perception, and overall sensory integration.
30% Improvement Time
to Recovery
By upregulating regeneration associated genes, the TPNS System harnesses the body’s inherent healing mechanisms to expedite functional gains.
Expanding Research Horizons
Building upon the success of this trial, our team is actively working on leveraging the knowledge gained to investigate the potential of our intervention in treating other injury sites. By adapting the techniques, protocols, and insights gleaned from this trial, we aim to extend our research to traumatic nerve injury in the hand (REGAIN™) and cubital tunnel (SELECT). See our clinical trials page for more information.
.png)
